Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. The company is headquartered in Tarrytown, New York and currently employs 600 full-time employees. The company went IPO on 2005-02-10. The firm is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
The most recent EPS for Prestige Consumer Healthcare Inc is $1.13, not beating expectations of $1.15.
How did Prestige Consumer Healthcare Inc PBH's revenue perform in the last quarter?
Prestige Consumer Healthcare Inc revenue for the last quarter is $1.13
What is the revenue estimate for Prestige Consumer Healthcare Inc?
According to 6 of Wall street analyst, the revenue estimate of Prestige Consumer Healthcare Inc range from $271.83M to $243.91M
What's the earning quality score for Prestige Consumer Healthcare Inc?
Prestige Consumer Healthcare Inc has a earning quality score of B+/54.518505. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Prestige Consumer Healthcare Inc report earnings?
Prestige Consumer Healthcare Inc next earnings report is expected in 2026-05-06
What are Prestige Consumer Healthcare Inc's expected earnings?
Prestige Consumer Healthcare Inc expected earnings is $284.83M, according to wall-street analysts.
Did Prestige Consumer Healthcare Inc beat earnings expectations?
Prestige Consumer Healthcare Inc recent earnings of $283.44M does not beat expectations.